Statements (65)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:Company
|
gptkbp:bfsLayer |
5
|
gptkbp:bfsParent |
gptkb:Fosun_Pharma
|
gptkbp:acquisition |
gptkb:Gland_Pharma
Amgen products |
gptkbp:ceo |
gptkb:Dr._Jianrong_Wu
|
gptkbp:clinical_trial |
Ongoing
|
gptkbp:collaborations |
Academic institutions
|
gptkbp:employees |
100-500
|
gptkbp:focus |
Healthcare
|
gptkbp:focus_area |
gptkb:healthcare_organization
gptkb:hospital gptkb:Mental_health gptkb:Company gptkb:Insurance_Company gptkb:Public_health gptkb:Biosimilars gptkb:Telecommunications_company Cell therapy Gastroenterology Gene therapy Health education Immunology Pain management Regenerative medicine Respiratory diseases Women's health Neurology Infectious diseases Healthcare accessibility Vaccination Dermatology Chronic disease management Chronic diseases Biologics Global health initiatives Elderly care Artificial intelligence in healthcare Patient engagement Data analytics in healthcare Healthcare innovation Vaccination programs Pharmaceutical supply chain Men's health Rare diseases Pharmaceutical research and development Digital health Healthcare policy advocacy |
gptkbp:founded |
gptkb:2015
|
gptkbp:headquarters |
gptkb:Borough
|
https://www.w3.org/2000/01/rdf-schema#label |
Fosun Pharma USA
|
gptkbp:industry |
Pharmaceuticals
|
gptkbp:investment |
Biotechnology companies
|
gptkbp:market |
gptkb:United_States
|
gptkbp:parent_company |
gptkb:Fosun_International
|
gptkbp:partnership |
gptkb:Bristol-Myers_Squibb
gptkb:Pfizer |
gptkbp:products |
Vaccines
Oncology drugs Cardiovascular drugs |
gptkbp:regulatory_compliance |
gptkb:FDA
|
gptkbp:research |
gptkb:Dr._Wei_Zhang
|
gptkbp:research_focus |
Innovative drugs
|
gptkbp:subsidiary |
gptkb:Fosun_International_Limited
|
gptkbp:website |
www.fosunpharmausa.com
|